Narayanan, B
Soh, P
Calhoun, V D
RuaƱo, G
Kocherla, M
Windemuth, A
Clementz, B A
Tamminga, C A
Sweeney, J A
Keshavan, M S
Pearlson, G D
Article History
Received: 18 November 2014
Revised: 27 April 2015
Accepted: 4 May 2015
First Online: 23 June 2015
Competing interests
: JAS has received support from Takeda, BMS, Lilly, Roche and Janssen. GR is the president of Genomas. MSK has received support from Sunovion. CAT has received funding from AStellas, Lilly, Iintracellular Therapies, Lundbeck and Pure Tech Ventures. All of these sources of support are unrelated to this study. The remaining authors declare no conflict of interest.